Yoshihiko Shimokawa

OPC-67683, a Nitro-Dihydro-Imidazooxazole Derivative with Promising Action against Tuberculosis In Vitro and In Mice

Makoto Matsumoto, Hiroyuki Hashizume, Tatsuo Tomishige et al. · PLoS Medicine · 2006 · 735 citations · Full text

Chemical analysis of a benzofuran derivative, 2-(2-ethylaminopropyl)benzofuran (2-EAPB), eight synthetic cannabinoids, five cathinone derivatives, and five other designer drugs newly detected in illegal products

Nahoko Uchiyama, Yoshihiko Shimokawa, Maiko Kawamura et al. · Forensic Toxicology · 2014 · 107 citations

Cannabis Use, Cathinone Derivatives, Psychoactive Drug +10

Pharmacokinetics and Metabolism of Delamanid, a Novel Anti-Tuberculosis Drug, in Animals and Humans: Importance of Albumin Metabolism In Vivo

Katsunori Sasahara, Yoshihiko Shimokawa, Yukihiro Hirao et al. · Drug Metabolism and Disposition · 2015 · 89 citations

Characterization of four new designer drugs, 5-chloro-NNEI, NNEI indazole analog, α-PHPP and α-POP, with 11 newly distributed designer drugs in illegal products

Nahoko Uchiyama, Satoru Matsuda, Maiko Kawamura et al. · Forensic Science International · 2014 · 74 citations

Pharmaceutical Research, Illegal Products, Drug Design +9

High performance liquid chromatographic methods for the determination of aripiprazole with ultraviolet detection in rat plasma and brain: Application to the pharmacokinetic study

Yoshihiko Shimokawa, Hitoshi Akiyama, Eiji Kashiyama et al. · Journal of Chromatography B · 2005 · 74 citations

Pharmacological Study, Medicine, Pharmacokinetic Study +8